The Un-audited Standalone and consolidated financial result of the Chemkart India Limited for the quarter and half year ended on 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemkart India, a BSE SME-listed trader and distributor of nutraceutical raw materials, reported its first results as a listed company for H1 FY26 (ended September 30, 2025). Consolidated revenue from operations grew 14.5% to Rs. 10,322.56 lakhs from Rs. 9,015.24 lakhs in the previous half year. Profit before tax rose to Rs. 1,380.83 lakhs (up from Rs. 1,188.28 lakhs), and profit after tax came in at Rs. 1,015.26 lakhs versus Rs. 889.57 lakhs earlier. Annualised EPS stood at Rs. 9.50. The company's net worth more than doubled to Rs. 12,022.41 lakhs, supported by the recent Rs. 6,448 lakh IPO (listed on BSE SME in July 2025), with cash and equivalents surging to Rs. 4,374.58 lakhs from Rs. 283.13 lakhs. The auditor (Bagaria & Co LLP) issued an unmodified limited review report, noting a change from the predecessor auditor. IPO proceeds are being deployed towards a new manufacturing facility at JNPA SEZ (only Rs. 50 lakhs utilised so far out of Rs. 3,468 lakhs allocated), with construction in its early piling stage.
Stable revenue and profit growth, a strong debt-free balance sheet with substantial IPO-funded cash, and progress on the manufacturing facility are positive signals for shareholders. However, weak operating cash flow (just Rs. 89.83 lakhs against Rs. 1,015 lakhs of profit) reflects stretched receivables and slow IPO deployment, which investors should monitor.